Frédéric Bodin

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +10

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine*

L Corea, Ondina Cardoni, Roberto Fogari et al. · Clinical Pharmacology & Therapeutics · 1996 · 135 citations

Evaluation of success of alveolar cleft bone graft performed at 5 years versus 10 years of age

C. Dissaux, Frédéric Bodin, Bruno Grollemund et al. · Journal of Cranio-Maxillofacial Surgery · 2015 · 106 citations

Regenerative Medicine, Craniofacial Disorder, Distraction Osteogenesis +9

Evaluation of 5-year-old children with complete cleft lip and palate: Multicenter study. Part 2: Functional results

C. Dissaux, Bruno Grollemund, Frédéric Bodin et al. · Journal of Cranio-Maxillofacial Surgery · 2015 · 64 citations

Cleft Lip, Pediatric Otolaryngology, Pediatric Swallowing +10

In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide

Paul L. M. van Giersbergen, Alexander Treiber, Martine Clozel et al. · Clinical Pharmacology & Therapeutics · 2002 · 64 citations